2026-04-12 · Mechanisms · 8 min
What a peptide actually is
Short chains of amino acids, receptor keys, and why half-life — not Instagram — decides whether a sequence is a medicine.
A peptide is a short chain of amino acids. Proteins are longer chains, often folded into domains; peptides are small enough to be synthesized as discrete sequences and, sometimes, to be used as drugs. Insulin is a peptide. So is oxytocin. So is the 15-residue fragment sold online as BPC-157. Sharing a chemical class does not make them equal as medicines.
Keys, not vitamins
Most therapeutic peptides work as ligands: they bind a receptor and turn a pathway up or down. GLP-1 receptor agonists mimic a gut hormone. GHRH analogs knock on the pituitary. Melanocortin agonists paint a different map entirely (pigment, appetite, desire). This is receptor pharmacology. It is not the same as eating protein, and it is not 'signaling' in the vague wellness sense.
Because they are amino-acid chains, unmodified peptides are usually digested if swallowed and cleaved quickly in blood by peptidases. That is why so many peptide drugs are injections, why some carry fatty-acid chains or PEG, and why an oral collagen powder and a weekly incretin pen should never be discussed as the same kind of object.
Half-life is the unglamorous constraint
- Native GLP-1 lasts minutes; semaglutide lasts about a week because it was engineered to.
- GHRH analogs with a Drug Affinity Complex bind albumin and linger; without it they do not.
- A sequence copied from a paper into a research vial does not inherit the approved drug's formulation, sterility, or pharmacokinetics.
Read the object, not the category
When someone says they are 'on peptides,' ask which sequence, which evidence grade, and whether it is an approved product. The word is a filing cabinet. The molecule is the file.
Class membership is not a clinical result.Strand, Vol. 1
Continue reading
- How to get peptides, and who pays
Doctor and pharmacy, compounding, trials, grey market, insurance — including Medicare’s 2026–2027 weight-loss program.
- Mitochondrial peptides: MOTS-c and the early map
A 16-residue sequence encoded in mtDNA, a cardiolipin-binding tetrapeptide in actual trials, and the distance between a mouse and a protocol.
- Research vials are not pharmacy drugs
Approved drugs, compounded copies, and “not for human use” powders are three different objects.